retatrutide and mounjaro vs Mounjaro: triple agonist versus dual agonist compared ๐ Weight Loss Medications 101:
Description
Beyond their joint-specific effects, GLP-1RAs have demonstrated systemic anti-inflammatory properties by decreasing levels of C-reactive protein, IL-6, IL-1, and TNF-, and reducing macrophage infiltration into vascular tissues[22]
This competitive pressure, combined with government negotiation and eventual generic entry, creates a trajectory toward more affordable GLP-1 access over the next five to ten years

The differences are significant, though context matters when interpreting them

Combining it with other metabolic drugs should only occur under medical supervision
Early escalation phase (5mg to 7.5mg) Research suggests the gastric emptying impact is strongest around the 5mg dose
